Evolus Inc. on Monday released first-quarter results that exceeded analysts’ expectations.
The Newport Beach-based aesthetics company reported revenue increased 7% to $73.1 million, surpassing the $72.46 million expected by analysts. Its adjusted EBITDA was $600,000, compared to a loss of $5.5 million a year ago. The shares on Tuesday rose 12% to $6.26 and a $412 million market cap (Nasdaq: EOLS).
“This performance reflects continued strength of the business and the benefit from structural improvements we implemented in 2025,” Chief Executive David Moatazedi said in a statement.
The company also reaffirmed full-year guidance of $327 million to $337 million, representing 10% to 13% growth from the prior year.
